These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
512 related items for PubMed ID: 23607261
21. Characterization of HBV DNA+/HBsAg- blood donors in Poland identified by triplex NAT. Brojer E, Grabarczyk P, Liszewski G, Mikulska M, Allain JP, Letowska M, Polish Blood Transfusion Service Viral Study Group. Hepatology; 2006 Dec; 44(6):1666-74. PubMed ID: 17133474 [Abstract] [Full Text] [Related]
23. What is the meaning of a nonresolved viral nucleic acid test-reactive minipool? Wang L, Chang L, Xie Y, Huang C, Xu L, Qian R, Zhu H, He Y, Li J, Huang H, Li W, Zhang K, Zhang R, Xie J, Sun Y, Li J. Transfusion; 2015 Feb; 55(2):395-404. PubMed ID: 25125223 [Abstract] [Full Text] [Related]
24. Detection of hepatitis B virus infection in German blood donors 2008-2015. Scheiblauer H, Heiden M, Funk M, Oberle D, Kreß J, Jork C, Chudy M. Vox Sang; 2020 Apr; 115(3):152-161. PubMed ID: 32023664 [Abstract] [Full Text] [Related]
30. Reduction of the risk of transfusion-transmitted viral infection by nucleic acid amplification testing in the Western Cape of South Africa: a 5-year review. Cable R, Lelie N, Bird A. Vox Sang; 2013 Feb; 104(2):93-9. PubMed ID: 22924987 [Abstract] [Full Text] [Related]
32. Sensitivity of individual-donation and minipool nucleic acid amplification test options in detecting window period and occult hepatitis B virus infections. Vermeulen M, Coleman C, Mitchel J, Reddy R, van Drimmelen H, Ficket T, Lelie N. Transfusion; 2013 Oct; 53(10 Pt 2):2459-66. PubMed ID: 23621791 [Abstract] [Full Text] [Related]
33. A mathematical approach to estimate the efficacy of individual-donation and minipool nucleic acid amplification test options in preventing transmission risk by window period and occult hepatitis B virus infections. Vermeulen M, van Drimmelen H, Coleman C, Mitchel J, Reddy R, Lelie N. Transfusion; 2014 Oct; 54(10):2496-504. PubMed ID: 24749834 [Abstract] [Full Text] [Related]
37. HBV NAT positive [corrected] blood donors in the early and late stages of HBV infection: analyses of the window period and kinetics of HBV DNA. Yoshikawa A, Gotanda Y, Itabashi M, Minegishi K, Kanemitsu K, Nishioka K, Japanese Red Cross NAT Screening Research Group. Vox Sang; 2005 Feb; 88(2):77-86. PubMed ID: 15720604 [Abstract] [Full Text] [Related]
38. Evaluation of a multiplex human immunodeficiency virus-1, hepatitis C virus, and hepatitis B virus nucleic acid testing assay to detect viremic blood donors in northern Thailand. Nantachit N, Thaikruea L, Thongsawat S, Leetrakool N, Fongsatikul L, Sompan P, Fong YL, Nichols D, Ziermann R, Ness P, Nelson KE. Transfusion; 2007 Oct; 47(10):1803-8. PubMed ID: 17880604 [Abstract] [Full Text] [Related]
40. Impact of nucleic acid testing for hepatitis B virus, hepatitis C virus, and human immunodeficiency virus on the safety of blood supply in Italy: a 6-year survey. Velati C, Romanò L, Fomiatti L, Baruffi L, Zanetti AR, SIMTI Research Group. Transfusion; 2008 Oct; 48(10):2205-13. PubMed ID: 18631163 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]